Comparing Mayzent vs Zeposia
| Mayzent (siponimod) | Zeposia (ozanimod) |
|
|---|
| Mayzent (siponimod) | Zeposia (ozanimod) |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Mayzent is an S1P receptor modulator that may be used to treat relapsing forms of multiple sclerosis in adults. It is only suitable for people with a certain CYP2C9 genetic type and genotype testing... View more |
Prescription only
Zeposia is an S1P receptor modulator that may be used to treat relapsing forms of multiple sclerosis or ulcerative colitis in adults. It requires a 7-day titration period and reduces lymphocyte... View more |
Related suggestions Popular comparisons
|
|||||||
| More about Mayzent (siponimod) | More about Zeposia (ozanimod) | ||||||||
| Ratings & Reviews | |||||||||
|
Mayzent has an average rating of 6.8 out of 10 from a total of 13 ratings on Drugs.com. 62% of reviewers reported a positive effect, while 31% reported a negative effect. |
Zeposia has an average rating of 8.8 out of 10 from a total of 8 ratings on Drugs.com. 88% of reviewers reported a positive effect, while 0% reported a negative effect. |
||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
|
View all Mayzent side effects |
View all Zeposia side effects |
||||||||
| Drug Class | |||||||||
| Generic Availability | |||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||
View all Mayzent prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
| Dosage Forms | |||||||||
|
|
||||||||
| Brand Names | |||||||||
|
N/A |
N/A |
||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
|
30 hours |
264 hours |
||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
| Pregnancy Category | |||||||||
|
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||
| Drug Interactions | |||||||||
|
A total of 742 drugs are known to interact with Mayzent:
|
A total of 928 drugs are known to interact with Zeposia:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
||||||||
| Disease Interactions | |||||||||
| First Approval Date | |||||||||
|
March 26, 2019 |
March 25, 2020 |
||||||||
| WADA Class View classifications | |||||||||
|
N/A |
N/A |
||||||||
| More Information | |||||||||
| Patient Resources | |||||||||
| Professional Resources | |||||||||
| Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.